Context Matters


Patient-Reported Outcomes in Oncology: If No One Pays Attention to Data, Does it Really Exist?

October 02, 2013

In a recent piece published in the New England Journal of Medicine, oncologist Dr. Ethan Basch talks about his perspective that patient-reported outcomes (PROs) are not widely used in the development process for cancer drugs because they are not often measured in clinical trials.

Redefining Cancer May Change the Orphan Status of Cancer Drugs

August 19, 2013

A recent NY Times piece by Tara Parker-Pope reported on the recommendation by a group at the National Cancer Institute to change both the definition of cancer as well as treatment and detection techniques.